Abstract
Clinical trials in children are important and challenging. Many advances in pediatric health have occurred as a result of clinical trials, ranging from the polio vaccine to chemotherapy for childhood leukemia. Nevertheless, the majority of medications prescribed to children have never been evaluated in them. Relatively recent programs to encourage testing of drugs in children have yielded important new information about pharmacokinetics and pharmacodynamics in pediatric populations, often contrary to what might have been expected. Trials are required, therefore, in order to determine not only the effects of drugs but also safe doses of medications in light of developmental changes throughout childhood. In addition, clinical trials are necessary in children because they have conditions that adults may not have. Finally, as in the case of early treatment for childhood leukemia, trials in children can help inform treatment in adults with similar conditions. In the current era, there are multiple regulations and strategies to optimize safety of pediatric participants in trials. Trial design in children follows the same principles as any other trial, although particular attention needs to be paid to burden on the child and family and understanding parental perceptions of clinical trials. Pediatric drug formulations and devices may be particularly challenging to develop.
The content of this chapter is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health.
References
(1932) BERLIN: appeal taken from the decision in the Luebeck case. JAMA 98(15):1316–1317
American Academy of Pediatrics Task Force on Sudden Infant Death (2005) The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. Pediatrics 116(5):1245–1255
Blalock ATH (1945) The surgical treatment of malformations of the heart. JAMA 128(3):189–202
Bogue C, DiMeglio LA, Maldonado S, Portman RJ, Smith PB, Sullivan JE, Thompson C, Woo H, Flinn S (2016) Special article: 2014 pediatric clinical trials forum. Pediatr Res 79(4):662–669
Boylston AW (2002) Clinical investigation of smallpox in 1767. N Engl J Med 346(17):1326–1328
Braunstein JB, Sherber NS, Schulman SP, Ding EL, Powe NR (2008) Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine (Baltimore) 87(1):1–9
Caldwell PH, Butow PN, Craig JC (2002) Pediatricians’ attitudes toward randomized controlled trials involving children. J Pediatr 141(6):798–803
Caldwell PH, Butow PN, Craig JC (2003) Parents’ attitudes to children’s participation in randomized controlled trials. J Pediatr 142(5):554–559
Centers for Disease Control and Prevention (2017) Polio elimination in the United States. https://www.cdc.gov/polio/us/index.html. Accessed 14 June 2019
Cotts T, Khairy P, Opotowsky AR, John AS, Valente AM, Zaidi AN, Cook SC, Aboulhosn J, Ting JG, Gurvitz M, Landzberg MJ, Verstappen A, Kay J, Earing M, Franklin W, Kogon B, Broberg CS, Alliance for Adult Research in Congenital Cardiology (2014) Clinical research priorities in adult congenital heart disease. Int J Cardiol 171(3):351–360
Cunningham-Erves J, Deakings J, Mayo-Gamble T, Kelly-Taylor K, Miller ST (2019) Factors influencing parental trust in medical researchers for child and adolescent patients’ clinical trial participation. Psychol Health Med 24(6):691–702
Holy Bible: New International Version (2011) Daniel 1:12–16. Biblica
Department of Health and Human Services (2018) Electronic code of Federal Regulations. https://www.ecfr.gov. Accessed 30 May 2019
European Parliament (2006) Regulation (EC) No 1901/2006 of the European Parliament and of the Council on Medicinal Products for Paediatric Use: L 378/371–319. https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/reg_2006_1901/reg_2006_1901_en.pdf. Accessed 30 May 2019
Field MJ, Behrman RE (eds) (2004) Ethical conduct of clinical research involving children. National Academies Press, Washington, DC
Food and Drug Administration (2018a) FDA guidance, use of liquids and/or soft foods as vehicles. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM614401.pdf. Accessed 30 May 2019
Food and Drug Administration (2018b) Code of federal regulations title 21: subpart H–accelerated approval of new drugs for serious life threatening illnesses. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=314&showFR=1&subpartNode=21:5.0.1.1.4.8. Accessed 29 May 2019
Forrest SJ, Geoerger B, Janeway KA (2018) Precision medicine in pediatric oncology. Curr Opin Pediatr 30(1):17–24
Francis TJ (1955) Evaluation of the 1954 poliomyelitis vaccine field trial: further studies of results determining the effectiveness of poliomyelitis vaccine (Salk) in preventing paralytic poliomyelitis. J Am Med Assoc 158:1266–1270
Frei E, Freireich EJ, Gehan E, Pinkel D, Holland JF, Selawry O, Haurani F, Spurr CL, Hayes DM, James GW, Rothberg H, Sodee DB, Rundles RW, Schroeder LR, Hoogstraten B, Wolman IJ, Traggis DG, Cooper T, Gendel BR, Ebaugh F, Taylor R (1961) Studies of sequential and combination antimetabolite therapy in acute leukemia: 6-mercaptopurine and methotrexate. Blood 18:431–454
Greenberg RG, Gamel B, Bloom D, Bradley J, Jafri HD, Nambiar S, Wheeler C, Tiernan R, Smith PB, Roberts J, Benjamin DK Jr (2018) Parents’ perceived obstacles to pediatric clinical trial participation: findings from the clinical trials transformation initiative. Contemp Clin Trials Commun 9:33–39
Gross RE, Hubbard JP (1939) Surgical ligation of a patent ductus arteriosus: report of first successful case. JAMA 112:729–731
Guary J (2004) Only a quarter (25%) of U.S. adults would consider allowing a child of theirs to participate in a clinical research study. Health Care News 4(17):1–8
Haig GM, Bockbrader HN, Wesche DL, Boellner SW, Ouellet D, Brown RR, Randinitis EJ, Posvar EL (2001) Single-dose gabapentin pharmacokinetics and safety in healthy infants and children. J Clin Pharmacol 41(5):507–514
Hoberman A, Shaikh N, Bhatnagar S, Haralam MA, Kearney DH, Colborn DK, Kienholz ML, Wang L, Bunker CH, Keren R, Carpenter MA, Greenfield SP, Pohl HG, Mathews R, Moxey-Mims M, Chesney RW (2013) Factors that influence parental decisions to participate in clinical research: consenters vs nonconsenters. JAMA Pediatr 167(6):561–566
Hoffman TM, Taeed R, Niles JP, McMillin MA, Perkins LA, Feltes TF (2007) Parental factors impacting the enrollment of children in cardiac critical care clinical trials. Pediatr Cardiol 28(3):167–171
Hoppu K, Koskimies O, Holmberg C, Hirvisalo EL (1991) Pharmacokinetically determined cyclosporine dosage in young children. Pediatr Nephrol 5(1):1–4
Le J, Bradley JS (2018) Optimizing antibiotic drug therapy in pediatrics: current state and future needs. J Clin Pharmacol 58(Suppl 10):S108–S122
Lu H, Rosenbaum S (2014) Developmental pharmacokinetics in pediatric populations. J Pediatr Pharmacol Ther 19(4):262–276
Maayan-Metzger A, Kedem-Friedrich P, Kuint J (2008) Motivations of mothers to enroll their newborn infants in general clinical research on well-infant care and development. Pediatrics 121(3):e590–e596
Marceau LD, Welch LC, Pemberton VL, Pearson GD (2016) Educating parents about pediatric research: children and clinical studies website qualitative evaluation. Qual Health Res 26(8):1114–1122
Marceau LD, Cho E, Coleman J, Liao W, Dennin S (2018) Evaluating the film if not for me: children and clinical studies. Clin Pediatr (Phila) 328–335. https://doi.org/10.1177/0009922818817799
Miller VA, Drotar D, Burant C, Kodish E (2005) Clinician-parent communication during informed consent for pediatric leukemia trials. J Pediatr Psychol 30(3):219–229
Morris MC, Besner D, Vazquez H, Nelson RM, Fischbach RL (2007) Parental opinions about clinical research. J Pediatr 151(5):532–537, 537 e531–535
Mudd LM, Pham X, Nechuta S, Elliott MR, Lepkowski JM, Paneth N, Michigan Alliance for the National Children’s Study (2008) Prenatal care and delivery room staff attitudes toward research and the National Children’s Study. Matern Child Health J 12(6):684–691
National Institutes of Health (1998) NIH policy and guidelines on the inclusion of children as participants in research involving human subjects. https://grants.nih.gov/grants/guide/notice-files/not98-024.html. Accessed 30 May 2019
Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP et al (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315(6):341–347
Newburger JW, Sleeper LA, Gaynor JW, Hollenbeck-Pringle D, Frommelt PC, Li JS, Mahle WT, Williams IA, Atz AM, Burns KM, Chen S, Cnota J, Dunbar-Masterson C, Ghanayem NS, Goldberg CS, Jacobs JP, Lewis AB, Mital S, Pizarro C, Eckhauser A, Stark P, Ohye RG, Pediatric Heart Network Investigators (2018) Transplant-free survival and interventions at 6 years in the SVR trial. Circulation 137(21):2246–2253
Ohye RG, Sleeper LA, Mahony L, Newburger JW, Pearson GD, Lu M, Goldberg CS, Tabbutt S, Frommelt PC, Ghanayem NS, Laussen PC, Rhodes JF, Lewis AB, Mital S, Ravishankar C, Williams IA, Dunbar-Masterson C, Atz AM, Colan S, Minich LL, Pizarro C, Kanter KR, Jaggers J, Jacobs JP, Krawczeski CD, Pike N, McCrindle BW, Virzi L, Gaynor JW, for the Pediatric Heart Network Investigators (2010) Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 362(21):1980–1992
Pasquali SK, Lam WK, Chiswell K, Kemper AR, Li JS (2012) Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry. Pediatrics 130(5):e1269–e1277
Pemberton VL, Pearson GD (2019a) Children and clinical studies. http://www.childrenandclinicalstudies.org/. Accessed 29 May 2019
Pemberton VL, Pearson GD (2019b) Children and clinical studies – the kids files. http://www.childrenandclinicalstudies.org/the-kids-files. Accessed 29 May 2019
Pui CH, Evans WE (2013) A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol 50(3):185–196
Rajakumar K, Thomas SB, Musa D, Almario D, Garza MA (2009) Racial differences in parents’ distrust of medicine and research. Arch Pediatr Adolesc Med 163(2):108–114
Reich WT (1995) Encyclopedia of bioethics. Macmillan, New York. Appendix 2762–2763
Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, Green DM, Hammond S, Meadows ST, Mertens AC, Mulvihill JJ, Nathan PC, Neglia JP, Packer RJ, Rajaraman P, Sklar CA, Stovall M, Strong LC, Yasui Y, Zeltzer LK (2009) The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol 27(14):2308–2318
Shuster E (1997) Fifty years later: the significance of the Nuremberg Code. N Engl J Med 337(20):1436–1440
Singhal N, Oberle K, Darwish A, Burgess E (2004) Attitudes of health-care providers towards research with newborn babies. J Perinatol 24(12):775–782
Tait AR, Voepel-Lewis T, Malviya S (2004) Factors that influence parents’ assessments of the risks and benefits of research involving their children. Pediatrics 113(4):727–732
Torok RD, Li JS, Kannankeril PJ, Atz AM, Bishai R, Bolotin E, Breitenstein S, Chen C, Diacovo T, Feltes T, Furlong P, Hanna M, Graham EM, Hsu D, Ivy DD, Murphy D, Kammerman LA, Kearns G, Lawrence J, Lebeaut B, Li D, Male C, McCrindle B, Mugnier P, Newburger JW, Pearson GD, Peiris V, Percival L, Pina M, Portman R, Shaddy R, Stockbridge NL, Temple R, Hill KD (2018) Recommendations to enhance pediatric cardiovascular drug development: report of a multi-stakeholder think tank. J Am Heart Assoc 7(4):e007283. https://doi.org/10.1161/JAHA.117.007283
Tsukamoto K, Carroll KA, Onishi T, Matsumaru N, Brasseur D, Nakamura H (2016) Improvement of pediatric drug development: regulatory and practical frameworks. Clin Ther 38(3):574–581
Unguru Y, Sill AM, Kamani N (2010) The experiences of children enrolled in pediatric oncology research: implications for assent. Pediatrics 125(4):e876–e883
Varma S, Jenkins T, Wendler D (2008) How do children and parents make decisions about pediatric clinical research? J Pediatr Hematol Oncol 30(11):823–828
Wax PM (1995) Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act. Ann Intern Med 122(6):456–461
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Pearson, G.D., Burns, K.M., Pemberton, V.L. (2020). Clinical Trials in Children. In: Piantadosi, S., Meinert, C. (eds) Principles and Practice of Clinical Trials. Springer, Cham. https://doi.org/10.1007/978-3-319-52677-5_259-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-52677-5_259-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52677-5
Online ISBN: 978-3-319-52677-5
eBook Packages: Springer Reference MathematicsReference Module Computer Science and Engineering